Edition 44 – Disability, Health Screening, Barriers to Care, Social Bias, Artificial Intelligence
Disability and the Emergence of Digital Barriers to Health Screening Sara M. Bergstresser, PhD, MPH, MS Share on facebook Facebook Share on twitter Twitter Share on linkedin LinkedIn Citation Bergstresser S. Disability and the emergence of digital barriers to health screening HPHR. 2021;44. DOI:10.54111/0001/RR3 Disability and the Emergence of Digital Barriers to Health Screening […]
Edition 44 – Accessible Medical Education and TIC: Increasing Equitable Care for Disabled Patients
Accessible Medical Education and TIC: Increasing Equitable Care for Disabled Patients Christina Jean Su and Peppar EP Cyr Facebook Twitter LinkedIn Citation Su C, Cyr P. Accessible Medical Education and TIC: Increasing Equitable Care for Disabled Patients. HPHR. 2021;44. DOI:10.54111/0001/RR1 Disability and Public Health Abstract An estimated 1 in 4 U.S. adults has a disability, […]
Edition 36 – House Bill 488: North Carolina’s Opportunity to Meaningfully Impact Maternal and Infant Health Outcomes
House Bill 488: North Carolina’s Opportunity to Meaningfully Impact Maternal and Infant Health Outcomes By Tyler C. Fox, BA and Rishika Reddy, BS Share on facebook Facebook Share on twitter Twitter Share on linkedin LinkedIn Citation Fox T, Reddy R. House Bill 488: North Carolina’s Opportunity to meaningfully impact maternal and infant health outcomes. HPHR. […]
Edition 45 – Caution Is Required When Clinically Implementing AI Models: What the Covid-19 Pandemic Taught Us About Regulation and Validation
Caution Is Required When Clinically Implementing AI Models: What the COVID-19 Pandemic Taught Us About Regulation and Validation By Keerthi B. Harish and Yindalon Aphinyanaphongs Share on facebook Facebook Share on twitter Twitter Share on linkedin LinkedIn Citation Harish K, Aphinyanaphongs Y. Caution is required when clinically implementing ai models: what the COVID-19 pandemic taught […]
Edition 40 – AI to Transform the Drug Approval Process and De-Risk Drug Development
AI to Transform the Drug Approval Process and De-Risk Drug Development By Cherubin Manokaran Facebook Twitter LinkedIn Citation Manokaran C. AI to transform the drug approval process and de-risk drug development. HPHR. 2021;40. 10.54111/0001/NN4 AI to Transform the Drug Approval Process and De-risk Drug Development Abstract The public tends to view high drug prices through […]
The GOLDEN TRIAD OF EPD: Prevention (Part 2)
Stroke Reimagined By Stuti Chakraborty The Golden Triad of EPD in Stroke: Prevention (Part 2) Apart from early prediction or detection of stroke, and its related outcomes, it is also imperative to ensure the primary prevention of stroke. This is of relevance from a public health perspective because ensuring the health of billions of people […]
Stuti Chakraborty proposes the GOLDEN TRIAD OF EPD: Early Prevention and Detection in Stroke (Part 1)
Stroke Reimagined By Stuti Chakraborty Detection and Prediction of stroke outcomes have been recent advancements of AI-ML, especially with the help of imaging data The “EPD” In Stroke: Golden Triad of Early Prevention and Detection – Part 1 Through the past blogs and vlogs in this series, we have come to realise the utmost urgency […]
